Our hLAB’s capabilities for custom assay Development, Validation and tech Transfer to FDA, EMA and ICH guidelines according to GCLP ensuring optimised readouts for assays. Custom assay development extends to a wide range of assay types including viral infectivity assays, anti-viral drugs efficacy assessments, quantitative and qualitative diagnostic real-time RT-PCR, virus microneutralization assays and cell mediated immunity assessments including ELISA assays for the anti-drug antibody analysis, cytokines and chemokines biomarker, ELISpot and Flow Cytometry analysis.
